← Back

ACG Acquisition Co. Ltd.

ACG Metals Limited produces gold and silver in Europe. It owns 100% interest in the Gediktepe copper-gold mine located in Turkey. It also focuses on copper and zinc production. The company was founded in 2024 and is based in Road Town, the British Virgin Islands.

Price · split & dividend adjusted
News & notes moving ACG.LSE
Critical Materials & Supply Chain

ACG Acquisition Targets August Copper-Zinc Output at Gediktepe Flotation Plant

ACG Acquisition is nearing a major operational shift at its Gediktepe mine in western Turkey, with the new flotation plant for copper and zinc concentrate now in commissioning and first production targeted by the end of August. Management said the company's 2026 guidance is 20,000 to 22,000 tonnes of copper equivalent, while the mine's oxide output has already exceeded full-year guidance in the first half due to better recoveries and improved processing technology. Looking ahead, ACG sees the sulfide plant and future copper-zinc output as key to improving liquidity, debt metrics and refinancing options, with management also signaling potential dividends once restrictive bonds are refinanced.
MarketBeat·36dRead more ▾
Critical Materials & Supply Chain

ACG Metals hits full-year oxide output target in six months

ACG Metals beat its full-year oxide production target in just six months, helped by a 64% jump in its realised gold price to $4,838 an ounce. First copper and zinc concentrate production is now expected in August. Rockfire Resources returned strong zinc and silver grades at its Molaoi project in Greece, with preliminary readings showing zinc values as high as 37.7%, and is fast-tracking feasibility studies and permit applications to reopen underground workings. Sunda Energy applied for a permit to explore an offshore area of New Zealand's Taranaki Basin covering around 645 square kilometres, triggering a three-month window for competing bids. CelLBxHealth remains on track for revenues of at least £2.1 million this year, up 50% on 2025, while searching for a new chief executive with no impact on trading expected. Poolbeg Pharma raised £3.5 million through a placing to fund two clinical trials and strengthen partnering discussions, extending its cash runway into the second quarter of 2028.
Yahoo Finance·44dRead more ▾